IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 143 filers reported holding IMMUNOGEN INC in Q1 2014. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,036,058 | -16.5% | 254,320 | -0.7% | 0.02% | -16.7% |
Q2 2023 | $4,830,814 | +117.1% | 256,005 | -55.8% | 0.02% | +100.0% |
Q1 2023 | $2,225,645 | +30.2% | 579,595 | +68.2% | 0.01% | +28.6% |
Q4 2022 | $1,709,191 | +33.9% | 344,595 | +29.1% | 0.01% | +16.7% |
Q3 2022 | $1,276,000 | +6.4% | 266,845 | +0.2% | 0.01% | +20.0% |
Q2 2022 | $1,199,000 | -53.2% | 266,445 | -50.5% | 0.01% | -44.4% |
Q1 2022 | $2,563,000 | -35.5% | 538,410 | +0.5% | 0.01% | -25.0% |
Q4 2021 | $3,973,000 | +35.9% | 535,485 | +3.9% | 0.01% | +20.0% |
Q3 2021 | $2,923,000 | -13.9% | 515,600 | +0.1% | 0.01% | -16.7% |
Q2 2021 | $3,393,000 | -18.8% | 514,909 | -0.2% | 0.01% | -25.0% |
Q1 2021 | $4,178,000 | +207.9% | 515,800 | +145.2% | 0.02% | +220.0% |
Q4 2020 | $1,357,000 | +122.5% | 210,400 | +24.2% | 0.01% | +66.7% |
Q3 2020 | $610,000 | -21.2% | 169,370 | +0.7% | 0.00% | -25.0% |
Q2 2020 | $774,000 | +36.7% | 168,270 | +1.5% | 0.00% | 0.0% |
Q1 2020 | $566,000 | -37.6% | 165,858 | -6.6% | 0.00% | -20.0% |
Q4 2019 | $907,000 | +116.0% | 177,656 | +2.3% | 0.01% | +150.0% |
Q3 2019 | $420,000 | +16.0% | 173,699 | +4.3% | 0.00% | 0.0% |
Q2 2019 | $362,000 | -13.6% | 166,599 | +122.4% | 0.00% | -33.3% |
Q1 2019 | $419,000 | +14.5% | 74,907 | +14.4% | 0.00% | 0.0% |
Q4 2018 | $366,000 | +245.3% | 65,473 | +272.6% | 0.00% | – |
Q4 2014 | $106,000 | -57.6% | 17,571 | -25.5% | 0.00% | – |
Q3 2014 | $250,000 | -2.0% | 23,584 | +9.3% | 0.00% | – |
Q2 2014 | $255,000 | -22.7% | 21,584 | -2.5% | 0.00% | -100.0% |
Q1 2014 | $330,000 | -6.8% | 22,146 | -8.3% | 0.00% | 0.0% |
Q4 2013 | $354,000 | -18.4% | 24,146 | -5.5% | 0.00% | 0.0% |
Q3 2013 | $434,000 | +4.8% | 25,555 | +2.2% | 0.00% | 0.0% |
Q2 2013 | $414,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |